Huang James
SEC Form 4 insider trading activity
Huang James has filed 2 SEC Form 4 filings (2 transaction rows) across 1 company, with disclosures dating back to 2026. 2 of those filings fall inside the rolling window. Most recent filing: Jun 2, 2026.
On the most recent filing, Huang James is listed as Director at Connect Biopharma Holdings Ltd. Inside the rolling window, Huang James reported 2 open-market purchases totaling $4.4M in CNTB and no open-market sales. The largest disclosed transaction in the window is a purchase of 1,160,000 CNTB shares on Mar 31, 2026, worth $4.0M.
Companies traded
Other insiders at CNTB
Insider Buying
$4.4M
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Huang James made?
Huang James has filed 2 SEC Form 4 filings (2 transaction rows) across 1 company since 2026.
Which companies does Huang James trade?
Huang James has filed SEC Form 4 disclosures for 1 company, including CNTB.
When was Huang James's most recent SEC Form 4 filing?
Huang James's most recent SEC Form 4 filing on Tracefour is dated Jun 2, 2026.
What is Huang James's total buy and sell value in the current window?
Inside the rolling retention window, Huang James bought $4.4M and sold $0 based on SEC Form 4 filings.
What was Huang James's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 1,160,000 CNTB shares on 2026-03-31, worth $4.0M, per SEC Form 4 filings.